Open Beta
MetriLume

US marketsONCO

SEC-sourced researchBeta

ONCO

Onconetix, Inc.

Company comparison ↗

Data passport

CIK
0001782107
Exchange
Nasdaq
Business activity
— · SIC 2834
Financial inputs
6/6
Filing date
Oct 7, 2026
SEC registry record
Operating company

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2024: 2,524,116.0000 USD; December 2025: 815,371.0000 USD2.5M USD0 USD0December 2024December 2025
ONCO · Exact amounts and source periods · USD
Period endRevenueFiling date
December 20242,524,116.0000Mar 13, 2026
December 2025815,371.0000Mar 13, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 2025815,371.0000-14,032,342.0000-9,678,390.000024,926,638.00009,160,287.0000Mar 13, 2026
December 20242,524,116.0000-58,691,023.0000-10,495,816.000028,181,563.000018,571,008.0000Mar 13, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenues$815.37KDecember 2025Mar 13, 202610-K
Previous period revenueRevenues$2.52MDecember 2024Mar 13, 202610-K
Net incomeNetIncomeLoss-$14.03MDecember 2025Mar 13, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities-$9.68MDecember 2025Mar 13, 202610-K
Total assetsAssets$24.93MDecember 2025Mar 13, 202610-K
Total liabilitiesLiabilities$9.16MDecember 2025Mar 13, 202610-K

New filings

Explore methodology ↗